文献速递妇科

老年卵巢癌患者中BRCA状态的分布及其预后作用

Distribution and prognostic role of BRCA status in elderly ovarian cancer patients.
PubMed 文献 · Gynecol Oncol · 2024-01-22

这是一项回顾性单机构研究,纳入1840例已知BRCA状态的卵巢癌患者,分析BRCA突变率随年龄的变化及对生存的影响。BRCA突变率从<50岁患者的49.7%降至≥80岁患者的18.8%;在老年人群中,BRCA突变者无病生存期(27.2个月 vs 16.5个月,p=0.001)和癌症特异性生存期(117.6个月 vs 43.1个月,p=0.001)均优于野生型。多因素分析显示,在老年女性中,初始手术和BRCA突变是影响生存的独立因素。

要点

  • BRCA突变率随年龄增长而下降,<50岁为49.7%,≥80岁为18.8%。
  • 老年卵巢癌患者中,BRCA突变者无病生存期和癌症特异性生存期均优于野生型。
  • 多因素分析显示,老年女性中初始手术和BRCA突变是影响生存的独立因素。

核心结论

  • 老年患者预后较差由多种因素导致,包括身体状况和合并症、治疗不足以及最重要的疾病特征;BRCA突变仍是影响复发风险和疾病死亡风险的最强独立预后因素。

研究设计与样本

  • 回顾性单机构研究,纳入1840例确诊卵巢癌且已知BRCA状态的患者,收集临床和手术特征,并按年龄组分析BRCA突变状态的分布。

主要发现

  • BRCA突变率随年龄范围下降,从<50岁患者的49.7%降至≥80岁女性的18.8%。
  • 在老年人群中,BRCA突变者相比野生型患者,无病生存期为27.2个月 vs 16.5个月(p=0.001)。
  • 在老年人群中,BRCA突变者相比野生型患者,癌症特异性生存期为117.6个月 vs 43.1个月(p=0.001)。
  • 多因素分析显示,在老年女性中,初始手术和BRCA突变是影响生存的独立因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In the era of target therapy and personalized medicine, BRCA mutational status has a major influence on survival in ovarian cancer patients. Our aim is to verify if the poorer prognosis of elderly ovarian cancer patients can be related to the biology of the tumor beyond their own morbidities and/or suboptimal treatments. METHODS: This is a retrospective single-institution study evaluating prognosis of patients with a diagnosis of ovarian cancer and known BRCA status. We collected clinical and surgical characteristics and the distribution of BRCA mutational status according to age groups. RESULTS: 1840 patients were included in the analysis. The rate of BRCA mutated decreased over age-range from 49.7% in patients aged <50 years to 18.8% in ≥80 years old women. The prognostic role of BRCA status on survival is maintained when focusing on the elderly population, with improved Disease Free Survival (27.2 months vs 16.5 months for BRCA mutated and wild type respectively, p = 0.001) and Cancer Specific Survival (117.6 months vs 43.1 months for BRCA mutated and wild type respectively, p = 0.001) for BRCAmut compared to BRCAwt patients. In the multivariable analysis, among elderly women, upfront surgery and BRCA mutation are independent factors affecting survival. CONCLUSIONS: Elderly patients experiment a poorer prognosis due to multiple factors that include both their medical condition and comorbidities, under-treatment and most importantly disease characteristics. We found that beyond disparities, BRCA mutation is still the strongest independent prognostic factor affecting both the risk of recurrence and death due to disease.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Tortorella L, Cappuccio S, Giannarelli D, et al. Distribution and prognostic role of BRCA status in elderly ovarian cancer patients. Gynecol Oncol. 2024. PMID: 38262239. doi:10.1016/j.ygyno.2023.12.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。